1 | numerous | 4,106 |
2 | laparoendoscopic | 63 |
3 | countless | 31 |
4 | innumerable | 23 |
5 | ige-dependent | 11 |
6 | large-effect | 9 |
7 | lipid-containing | 7 |
8 | non-intrusive | 7 |
9 | already-known | 6 |
10 | nzrex | 6 |
11 | b56γ-pp2a | 5 |
12 | free-swimming | 5 |
13 | o-methyl | 5 |
14 | surmounting | 5 |
15 | bias.three | 4 |
16 | ethnicity-related | 4 |
17 | folate-related | 4 |
18 | isovolumically | 4 |
19 | lithic | 4 |
20 | non-adult | 4 |
21 | patient-targeted | 4 |
22 | plasma-mediated | 4 |
23 | qd-mediated | 4 |
24 | soprolife | 4 |
25 | taiho | 4 |
26 | alchemical | 3 |
27 | arsenogorceixite | 3 |
28 | functionally-related | 3 |
29 | galvanized | 3 |
30 | henoch | 3 |
31 | investigator-evaluated | 3 |
32 | nonurologic | 3 |
33 | relaxin-3-positive | 3 |
34 | 10,764 | 2 |
35 | 10366 | 2 |
36 | 9,373 | 2 |
37 | adherence.five | 2 |
38 | as-oct. | 2 |
39 | carbonised | 2 |
40 | cleft-palate | 2 |
41 | clinical/metabolic | 2 |
42 | described.a | 2 |
43 | foreign-predominant | 2 |
44 | highschool | 2 |
45 | katamnestic | 2 |
46 | large-celled | 2 |
47 | learnable | 2 |
48 | non-be | 2 |
49 | pyelonephritis-associated | 2 |
50 | reproduction-related | 2 |
51 | sit-induced | 2 |
52 | two-stroke | 2 |
53 | uro-oncological | 2 |
54 | vigoo | 2 |
55 | well-published | 2 |
56 | 1,571,764 | 1 |
57 | 10,742 | 1 |
58 | 100-cc | 1 |
59 | 144,113 | 1 |
60 | 2/4/a1 | 1 |
61 | 20,538 | 1 |
62 | 3652 | 1 |
63 | 40-year-long | 1 |
64 | 41,304 | 1 |
65 | 47.1.a | 1 |
66 | 5,519 | 1 |
67 | 5,842 | 1 |
68 | 738,710 | 1 |
69 | alpha-fe2o3-based | 1 |
70 | b-depleted | 1 |
71 | between-partner | 1 |
72 | bloodflow-based | 1 |
73 | bt-compatible | 1 |
74 | carbon-incorporated | 1 |
75 | chemical/ | 1 |
76 | client-dependent | 1 |
77 | cornel | 1 |
78 | coxl | 1 |
79 | cryoscopic | 1 |
80 | ctx-m-encoding | 1 |
81 | daclizumab-induced | 1 |
82 | denitrification-related | 1 |
83 | disheartening | 1 |
84 | electronmicroscopic | 1 |
85 | fair-and | 1 |
86 | fibrin-containing | 1 |
87 | fimh-mediated | 1 |
88 | finely-set | 1 |
89 | gad65-specifc | 1 |
90 | golga8-flanked | 1 |
91 | haemodynamic-independent | 1 |
92 | hsp70/inos | 1 |
93 | ict-enabled | 1 |
94 | institution/investigator-initiated | 1 |
95 | jnc-recommended | 1 |
96 | large-sampled | 1 |
97 | lichen-derived | 1 |
98 | lps/tlr/rp105 | 1 |
99 | lung.1 | 1 |
100 | ma-fortified | 1 |
101 | made-to-order | 1 |
102 | massage-based | 1 |
103 | md-2/tlr4-mediated | 1 |
104 | medrad | 1 |
105 | meta-analyzing | 1 |
106 | microcystin-contaminated | 1 |
107 | multiple-cross-over | 1 |
108 | musculoligamentous | 1 |
109 | n-3-oxododecanoyl | 1 |
110 | n-octane-induced | 1 |
111 | nct01783457 | 1 |
112 | needed.a | 1 |
113 | nonprespecified | 1 |
114 | nsf-comparable | 1 |
115 | over-precise | 1 |
116 | package-insert | 1 |
117 | patient-revealed | 1 |
118 | pharmacokinetic/ | 1 |
119 | promoting/endorsing | 1 |
120 | prospore2 | 1 |
121 | psoroptid | 1 |
122 | pvl-encoding | 1 |
123 | quiescin | 1 |
124 | recognition-related | 1 |
125 | routine-based | 1 |
126 | science-initiated | 1 |
127 | separately.two | 1 |
128 | staff-identified | 1 |
129 | standard-reviewed | 1 |
130 | syncytium-inducing | 1 |
131 | telehealth-supported | 1 |
132 | time-randomized | 1 |
133 | tmp/smx-sensitive | 1 |
134 | transareola | 1 |
135 | unusal | 1 |
136 | v212-002 | 1 |
137 | vexes | 1 |
1 | 1,571,764 | 1 |
2 | 10,742 | 1 |
3 | 10,764 | 2 |
4 | 100-cc | 1 |
5 | 10366 | 2 |
6 | 144,113 | 1 |
7 | 2/4/a1 | 1 |
8 | 20,538 | 1 |
9 | 3652 | 1 |
10 | 40-year-long | 1 |
11 | 41,304 | 1 |
12 | 47.1.a | 1 |
13 | 5,519 | 1 |
14 | 5,842 | 1 |
15 | 738,710 | 1 |
16 | 9,373 | 2 |
17 | adherence.five | 2 |
18 | alchemical | 3 |
19 | alpha-fe2o3-based | 1 |
20 | already-known | 6 |
21 | arsenogorceixite | 3 |
22 | as-oct. | 2 |
23 | b-depleted | 1 |
24 | b56γ-pp2a | 5 |
25 | between-partner | 1 |
26 | bias.three | 4 |
27 | bloodflow-based | 1 |
28 | bt-compatible | 1 |
29 | carbon-incorporated | 1 |
30 | carbonised | 2 |
31 | chemical/ | 1 |
32 | cleft-palate | 2 |
33 | client-dependent | 1 |
34 | clinical/metabolic | 2 |
35 | cornel | 1 |
36 | countless | 31 |
37 | coxl | 1 |
38 | cryoscopic | 1 |
39 | ctx-m-encoding | 1 |
40 | daclizumab-induced | 1 |
41 | denitrification-related | 1 |
42 | described.a | 2 |
43 | disheartening | 1 |
44 | electronmicroscopic | 1 |
45 | ethnicity-related | 4 |
46 | fair-and | 1 |
47 | fibrin-containing | 1 |
48 | fimh-mediated | 1 |
49 | finely-set | 1 |
50 | folate-related | 4 |
51 | foreign-predominant | 2 |
52 | free-swimming | 5 |
53 | functionally-related | 3 |
54 | gad65-specifc | 1 |
55 | galvanized | 3 |
56 | golga8-flanked | 1 |
57 | haemodynamic-independent | 1 |
58 | henoch | 3 |
59 | highschool | 2 |
60 | hsp70/inos | 1 |
61 | ict-enabled | 1 |
62 | ige-dependent | 11 |
63 | innumerable | 23 |
64 | institution/investigator-initiated | 1 |
65 | investigator-evaluated | 3 |
66 | isovolumically | 4 |
67 | jnc-recommended | 1 |
68 | katamnestic | 2 |
69 | laparoendoscopic | 63 |
70 | large-celled | 2 |
71 | large-effect | 9 |
72 | large-sampled | 1 |
73 | learnable | 2 |
74 | lichen-derived | 1 |
75 | lipid-containing | 7 |
76 | lithic | 4 |
77 | lps/tlr/rp105 | 1 |
78 | lung.1 | 1 |
79 | ma-fortified | 1 |
80 | made-to-order | 1 |
81 | massage-based | 1 |
82 | md-2/tlr4-mediated | 1 |
83 | medrad | 1 |
84 | meta-analyzing | 1 |
85 | microcystin-contaminated | 1 |
86 | multiple-cross-over | 1 |
87 | musculoligamentous | 1 |
88 | n-3-oxododecanoyl | 1 |
89 | n-octane-induced | 1 |
90 | nct01783457 | 1 |
91 | needed.a | 1 |
92 | non-adult | 4 |
93 | non-be | 2 |
94 | non-intrusive | 7 |
95 | nonprespecified | 1 |
96 | nonurologic | 3 |
97 | nsf-comparable | 1 |
98 | numerous | 4,106 |
99 | nzrex | 6 |
100 | o-methyl | 5 |
101 | over-precise | 1 |
102 | package-insert | 1 |
103 | patient-revealed | 1 |
104 | patient-targeted | 4 |
105 | pharmacokinetic/ | 1 |
106 | plasma-mediated | 4 |
107 | promoting/endorsing | 1 |
108 | prospore2 | 1 |
109 | psoroptid | 1 |
110 | pvl-encoding | 1 |
111 | pyelonephritis-associated | 2 |
112 | qd-mediated | 4 |
113 | quiescin | 1 |
114 | recognition-related | 1 |
115 | relaxin-3-positive | 3 |
116 | reproduction-related | 2 |
117 | routine-based | 1 |
118 | science-initiated | 1 |
119 | separately.two | 1 |
120 | sit-induced | 2 |
121 | soprolife | 4 |
122 | staff-identified | 1 |
123 | standard-reviewed | 1 |
124 | surmounting | 5 |
125 | syncytium-inducing | 1 |
126 | taiho | 4 |
127 | telehealth-supported | 1 |
128 | time-randomized | 1 |
129 | tmp/smx-sensitive | 1 |
130 | transareola | 1 |
131 | two-stroke | 2 |
132 | unusal | 1 |
133 | uro-oncological | 2 |
134 | v212-002 | 1 |
135 | vexes | 1 |
136 | vigoo | 2 |
137 | well-published | 2 |
1 | as-oct. | 2 |
2 | pharmacokinetic/ | 1 |
3 | chemical/ | 1 |
4 | 738,710 | 1 |
5 | lung.1 | 1 |
6 | 2/4/a1 | 1 |
7 | v212-002 | 1 |
8 | 10,742 | 1 |
9 | 5,842 | 1 |
10 | 3652 | 1 |
11 | prospore2 | 1 |
12 | 144,113 | 1 |
13 | 9,373 | 2 |
14 | 41,304 | 1 |
15 | 10,764 | 2 |
16 | 1,571,764 | 1 |
17 | lps/tlr/rp105 | 1 |
18 | 10366 | 2 |
19 | nct01783457 | 1 |
20 | 20,538 | 1 |
21 | 5,519 | 1 |
22 | 47.1.a | 1 |
23 | described.a | 2 |
24 | needed.a | 1 |
25 | b56γ-pp2a | 5 |
26 | transareola | 1 |
27 | 100-cc | 1 |
28 | gad65-specifc | 1 |
29 | nonurologic | 3 |
30 | lithic | 4 |
31 | clinical/metabolic | 2 |
32 | laparoendoscopic | 63 |
33 | electronmicroscopic | 1 |
34 | cryoscopic | 1 |
35 | katamnestic | 2 |
36 | medrad | 1 |
37 | daclizumab-induced | 1 |
38 | n-octane-induced | 1 |
39 | sit-induced | 2 |
40 | jnc-recommended | 1 |
41 | well-published | 2 |
42 | nonprespecified | 1 |
43 | staff-identified | 1 |
44 | ma-fortified | 1 |
45 | golga8-flanked | 1 |
46 | patient-revealed | 1 |
47 | ict-enabled | 1 |
48 | large-celled | 2 |
49 | large-sampled | 1 |
50 | alpha-fe2o3-based | 1 |
51 | massage-based | 1 |
52 | routine-based | 1 |
53 | bloodflow-based | 1 |
54 | carbonised | 2 |
55 | pyelonephritis-associated | 2 |
56 | md-2/tlr4-mediated | 1 |
57 | plasma-mediated | 4 |
58 | qd-mediated | 4 |
59 | fimh-mediated | 1 |
60 | science-initiated | 1 |
61 | institution/investigator-initiated | 1 |
62 | folate-related | 4 |
63 | denitrification-related | 1 |
64 | reproduction-related | 2 |
65 | recognition-related | 1 |
66 | functionally-related | 3 |
67 | ethnicity-related | 4 |
68 | microcystin-contaminated | 1 |
69 | carbon-incorporated | 1 |
70 | investigator-evaluated | 3 |
71 | patient-targeted | 4 |
72 | b-depleted | 1 |
73 | telehealth-supported | 1 |
74 | lichen-derived | 1 |
75 | standard-reviewed | 1 |
76 | time-randomized | 1 |
77 | galvanized | 3 |
78 | psoroptid | 1 |
79 | fair-and | 1 |
80 | non-be | 2 |
81 | bias.three | 4 |
82 | soprolife | 4 |
83 | two-stroke | 2 |
84 | learnable | 2 |
85 | nsf-comparable | 1 |
86 | innumerable | 23 |
87 | bt-compatible | 1 |
88 | over-precise | 1 |
89 | cleft-palate | 2 |
90 | arsenogorceixite | 3 |
91 | adherence.five | 2 |
92 | non-intrusive | 7 |
93 | tmp/smx-sensitive | 1 |
94 | relaxin-3-positive | 3 |
95 | syncytium-inducing | 1 |
96 | pvl-encoding | 1 |
97 | ctx-m-encoding | 1 |
98 | free-swimming | 5 |
99 | disheartening | 1 |
100 | lipid-containing | 7 |
101 | fibrin-containing | 1 |
102 | promoting/endorsing | 1 |
103 | surmounting | 5 |
104 | meta-analyzing | 1 |
105 | 40-year-long | 1 |
106 | henoch | 3 |
107 | uro-oncological | 2 |
108 | alchemical | 3 |
109 | unusal | 1 |
110 | cornel | 1 |
111 | highschool | 2 |
112 | coxl | 1 |
113 | o-methyl | 5 |
114 | n-3-oxododecanoyl | 1 |
115 | quiescin | 1 |
116 | already-known | 6 |
117 | taiho | 4 |
118 | vigoo | 2 |
119 | separately.two | 1 |
120 | made-to-order | 1 |
121 | between-partner | 1 |
122 | multiple-cross-over | 1 |
123 | vexes | 1 |
124 | hsp70/inos | 1 |
125 | countless | 31 |
126 | numerous | 4,106 |
127 | musculoligamentous | 1 |
128 | large-effect | 9 |
129 | finely-set | 1 |
130 | non-adult | 4 |
131 | foreign-predominant | 2 |
132 | ige-dependent | 11 |
133 | client-dependent | 1 |
134 | haemodynamic-independent | 1 |
135 | package-insert | 1 |
136 | nzrex | 6 |
137 | isovolumically | 4 |